U.S. regulators have approved the first RSV vaccine for pregnant women to protect their newborns

Stimulating the brain using electrodes could help ease symptoms of attention deficit hyperactivity disorder (ADHD) in children, a study has found. Transcranial random noise stimulation (tRNS) works by sending a mild electrical current to the brain through two electrodes on the scalp. The study, led by researchers from the University of Surrey and the Hebrew University of Jerusalem – and published in the Translational Psychiatry journal, explored the use of tRNS alongside cognitive training as a treatment for ADHD. Roi Cohen Kadosh, head of the School of Psychology and professor of cognitive neuroscience at the University of Surrey, said: “I believe that the scientific community is duty-bound to investigate and develop evermore effective and longer-lasting treatments for ADHD.” The clinical trial included 23 newly diagnosed and unmedicated children between the ages of six and 12, who were recruited from groups referred to the ADHD clinic by doctors, teachers, psychologists or parents. Researchers at the computerised neurotherapy lab at the Hebrew University of Jerusalem administered tRNS during cognitive training each weekday over a two-week period. The parents of 55% of the group reported “significant clinical improvement” in ADHD symptoms to researchers, compared to 17% in a control group that was given placebo brain simulation. Prof Kadosh said the findings demonstrate the treatment “has the potential to transform the lives of children and their families”. Future studies, with larger and more varied samples, should help establish this as a viable therapy for ADHD, and help us understand the underlying mechanisms of the disorder Dr Mor Nahum ADHD is a neurodevelopmental disorder and symptoms include hyperactivity, an inability to focus and impulsiveness. According to the National Institute for Health and Care Excellence (Nice), it is present in about 5% of children globally. Researchers are now preparing to start a larger clinical trial using tRNS and cognitive training. “If successful, this approach will be approved as a medical device for ADHD by the United States Food and Drug Administration,” Prof Kadosh said. Dr Mor Nahum is co-lead of the study and head of the computerised neurotherapy lab at the Hebrew University of Jerusalem. She added: “This is an important first step in offering new therapeutic options for ADHD. “Future studies, with larger and more varied samples, should help establish this as a viable therapy for ADHD, and help us understand the underlying mechanisms of the disorder.” Read More Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live Black LGBTQ+ icons everyone should know Ashley James: ‘We have a totally warped idea of what a mum should be’ Host Maya Jama’s glamorous Love Island outfits cost over £10,000

TL;DR: As of September 9, get this 3-in-1 Magnetic Wireless Charger in Black for only

Looking for a trailer that will satisfy your sweet tooth? Then behold the latest teaser

The best Labor Day Apple deals at a glance: Best AirPods deal Apple AirPods Pro

Apple is hosting its annual Worldwide Developers Conference (WWDC) on Monday, and like Microsoft’s Build,

Far from the crowds of Bodrum and Alaçatı, Turkey's Aegean coast is home to historic beach towns and idyllic islands. Ayvalık, famous for its olive oil mills, is one of the prettiest -- and nearby island Cunda makes for a perfect twin-center break.

SAO PAULO Carrefour Brasil said on Thursday it has entered into exclusive talks with Barzel Properties for the

A mother who felt she was being “eaten away” after hot flushes led to an incurable blood cancer diagnosis in her late 50s has urged women not to ignore symptoms. In the summer of 2022, Barbara Geraghty-Whitehead, 58, a school inclusion manager who lives in Cheshire, began to experience hot flushes, dizziness and she developed an ear infection. She said she “put it to the back of (her) mind”, but her symptoms persisted – and eventually, after months of hesitation, she visited her GP in September 2022 and underwent blood tests. Within a matter of hours, she received a phone call from her doctor, saying that they were concerned about how high her white blood cells were and that they suspected it could be cancer. One week later, after further tests, Geraghty-Whitehead was told she has chronic myeloid leukaemia (CML) and it is incurable. “You say you want to carry on as much as normal, but from that second nothing else was going to be normal anymore,” she told PA Real Life. “I wanted to go in and for them to say, ‘No, it was a mistake, it’s something else,’ but they didn’t, they said it was CML.” Geraghty-Whitehead started taking chemotherapy tablets that same day – and despite experiencing side effects of fatigue, nausea, acid reflux, and a loss of taste, nearly one year later she has responded well to treatment and has been able to see her daughter get married in Cyprus. After nearly ignoring her own symptoms, she wants to encourage others not to “make excuses”, as “people need to know the signs so they can get diagnosed early”. “When I was first diagnosed, you don’t know where to start and that in itself is overwhelming, but the support I’ve received has been fantastic,” Geraghty-Whitehead said. “I think about [my diagnosis] every day and it is hard and I do get upset, but now I’ve just got to face the fact that this is the new me. “I’m never going to be the person that I was before but I’m going to recreate the new me.” Geraghty-Whitehead said she almost ignored her cancer symptoms and attributed her hot flushes to warm weather and “thought no more of it”. She said she did not think it was related to menopause, as she had already been taking hormone replacement therapy (HRT) patches for years to treat her bone pain. “I started not feeling right and I couldn’t figure out what it was, but I didn’t do anything about it – I just left it,” she explained. She added: “I never ever got hot flushes. Even though I was put on HRT patches, it was mainly for my bone pain, so I just put it to the back of my mind and I thought no more of it.” Looking back now, she realises she should have acted sooner – but on September 16, she visited her GP and underwent blood tests. Days later, on the day of the Queen’s funeral, she found herself sat in an empty hospital waiting room, preparing for further blood tests – and by the end of that week, on September 23, Geraghty-Whitehead received the news she has CML and the following minutes felt like “a blur”. “Everything happened so fast, it was just like a roller-coaster,” she said. “I think it was worse waiting for the blood test results because I didn’t know what type of cancer it was, whether I was going to live, whether I was going to die. “But all I wanted was to get the very first tablet into my body, as I felt like I was being eaten away because it was in my blood and your blood travels everywhere.” Geraghty-Whitehead started treatment the same day she was diagnosed, which she said was the “first positive move”. Although she was told her CML is incurable, doctors reassured her other patients had responded well to the chemotherapy tablets she needed to take daily, and this gave her hope. For more information and support, visit Leukaemia Care’s website here: leukaemiacare.org.uk Read More 9 arthritis myths we all need to stop believing What happens at a sexual health check-up? 9 key signs of leukaemia, as awareness is called ‘non-existent’ Cancer-hit dad who planned own funeral outlives three-week prognosis What happens at a sexual health check-up? 9 arthritis myths we all need to stop believing

Air Canada broke even in the first quarter, taking advantage of pent-up demand for travel and lower fuel

When it comes to our favorite cleaning products or the latest summer fashions, we know that Amazon's e-shelves are filled to the brim with incredible options. But did you know that the mega-retailer also contains a treasure trove of sex toys? Just by setting the search category to "Health & Household," you can unveil over 30,000 sexual wellness products including vibrators, lubricants, and sex accessories.

Girls miss more school or college days due to periods than any other reason – including colds, mental health or truancy, according to a new report. Periods cause girls to be absent from school or college for three days a term on average, compared with colds and flu (2.6 days), mental health (1.9 days) and truancy (1.2 days), the data released by washroom provider phs Group has revealed. This equates to 54 lost education days over the course of their teen years, the equivalent of 11 academic weeks. The findings form part of phs Group’s Period Equality: Breaking the Cycle report, now in its third year, for which Censuswide polled 1,262 girls aged 13-18 years across the UK. The majority (82%) cited cramps as the main reason for this, while almost one in five (19%) said they stay away from lessons because they’re embarrassed about being on their period, and one in 12 (8%) said it’s because no period products were available to them. This is despite the introduction of period equality measures in recent years, designed to improve access to free period products in education settings. “It’s important to recognise that huge advances have been made in giving girls access to free period products in schools across the UK. What we must do now is close the gap between providing schools with all the products they need and getting them into the hands of any girls that need them, for whatever reason,” said Kelly Greenaway, period equality lead at phs Group. “We know from our own data providing schools with products, that they have more than enough for their girls, so we need to tackle the misconceptions around free access to products in washrooms, and the stigma and shame that goes hand-in-hand with failing to have open conversations about menstruation.” Since the launch of the Government’s Period Product Scheme in January 2020, which provides free period products to education settings in England, via phs Group, 99% of secondary schools and 94% of post-16 organisations have ordered products through the scheme. However, the report published today highlights how periods remain a barrier to education for many girls – with the number of girls missing school due to their periods almost the same for the 2023 findings (54%) as the findings in 2019 (52%), before free sanitary product schemes were introduced. Despite the roll-out of such schemes, over half (52%) of the students surveyed said they did not find period products freely available in their school and college settings, while one in seven (14%) said they did not know if they were available. To help tackle the issue and raise awareness, phs Group is launching a new period equality podcast – called The Blobcast: Free The Period – hosted by menstrual wellbeing and confidence educator Kasey Robinson. Robinson said: “I know too well about the barriers facing so many of us when it comes to our menstrual health. It’s simply not enough to blame absenteeism figures on access to products alone. “On the ground, the story is clear: we aren’t being educated, supported and informed enough about periods. Menstruation is still a taboo subject, and our experience is a secret to keep to ourselves and something we feel forced to hide. In education settings, this is leading to more and more girls staying away from school. “Without workshops, learning resources and the support for and from teachers and caregivers, this issue will stay the same, or get worse,” Robinson added. “It should not be a revolutionary act to teach people about periods, it’s a right. We need to break the cycle of shame and encourage open and honest conversations about periods – exactly what The Blobcast is seeking to do.” The Blobcast: Free The Period launches on all free streaming platforms on October 18. More information can be found at www.phs.co.uk/TheBlobcast.